Abstract GS3-08: Pathological complete response predicts event-free and distant disease-free survival in the I-SPY2 TRIALDouglas Yee, Si Fan, Christina Yau et al.|Cancer Research|2018Cited by 16
A clinical validation study of MammaPrint in hormone receptor-positive breast cancer from the Austrian Breast and Colorectal Cancer Study Group 8 (ABCSG-8) biomarker cohortPeter Dubsky, Martin Filipits, LJ van't Veer et al.|ESMO Open|2021Cited by 16